Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting Read more about Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting
Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020 Read more about Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020
Agios at RBC Capital Markets 2020 Global Healthcare Conference Read more about Agios at RBC Capital Markets 2020 Global Healthcare Conference
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response Read more about Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response
Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020 Read more about Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020
Q1 2020 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q1 2020 Agios Pharmaceuticals Inc Earnings Conference Call
Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency Read more about Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency
Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb Read more about Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb
Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator Read more about Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator
Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020 Read more about Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020